- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma

Emma Cooper

Emma is Digital Editor at Pf.
464 POSTS

New nirsevimab data reinforces efficacy against RSV in infants

Results from Phase 3 trials have demonstrated that nirsevimab,...

STORM Therapeutics awarded grant to develop novel COVID-19 therapy

Biotechnology company, STORM Therapeutics, has announced that it has...

WHO recommends Veklury for patients at high-risk of hospitalisation

The World Health Organisation has recommended remdesivir (Veklury®) for...

MOST READ ON PF

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription